Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Tommi Kuorilehto"'
Autor:
Niku Oksala, Marianne Jaroma, Juha-Pekka Pienimäki, Tommi Kuorilehto, Teemu Vänttinen, Antti Lehtomäki, Veli-Pekka Suominen, Prasun Dastidar, Kimmo Mäkinen, Timo Erkinjuntti, Juha-Pekka Salenius
Publikováno v:
Cerebrovascular Diseases Extra, Vol 4, Iss 2, Pp 122-131 (2014)
Background: Cerebral white matter lesions (WMLs) predict long-term survival of conservatively treated acute stroke patients with etiology other than carotid stenosis. In carotid endarterectomy patients, WMLs are associated with severe carotid stenosi
Externí odkaz:
https://doaj.org/article/17f47f6eef2f4340937fd1b380c3b57b
Autor:
Niku Oksala, Velipekka Suominen, Terho Lehtimäki, Niina Khan, Leo-Pekka Lyytikäinen, Tommi Kuorilehto, Antti Lehtomäki, Jahangir Khan, Ilkka Seppälä
Publikováno v:
World journal of surgery. 42(4)
Individuals treated for abdominal aortic aneurysms (AAAs) are high-risk patients in whom better risk prediction could improve survival. Contemporary serum lipid parameters, such as apolipoproteins and lipoprotein subfractions, may improve or compleme
Autor:
Velipekka Suominen, Juha-Pekka Pienimäki, Juha-Pekka Salenius, Timo Erkinjuntti, Niku Oksala, Antti Lehtomäki, Kimmo Mäkinen, Marianne Jaroma, Teemu Vänttinen, Prasun Dastidar, Tommi Kuorilehto
Publikováno v:
Cerebrovascular Diseases Extra, Vol 4, Iss 2, Pp 122-131 (2014)
Cerebrovascular Diseases Extra
Cerebrovascular Diseases Extra
Background: Cerebral white matter lesions (WMLs) predict long-term survival of conservatively treated acute stroke patients with etiology other than carotid stenosis. In carotid endarterectomy patients, WMLs are associated with severe carotid stenosi
Autor:
Sirkku Peltonen, Minna Pöyhönen, Juha Peltonen, Tommi Kuorilehto, Pekka Leinonen, Eetu Heervä, Kalervo Väänänen
Publikováno v:
Calcified Tissue International. 92:23-27
The current study is based on our earlier investigation carried out in 1999, where bone mineral density (BMD) of 35 neurofibromatosis type 1 (NF1) patients was measured and osteoporosis was shown to be common in NF1. The findings have been confirmed
Autor:
Tommi Kuorilehto, Anna Koffert, Hannu T. Aro, Sirkku Peltonen, Elina Jokinen, Juha Peltonen, Eetu Heervä
Publikováno v:
Journal of Bone and Mineral Research. 27(11):2333-2337
Neurofibromatosis 1 (NF1, von Recklinghausen's disease) is an autosomal dominant neurocutaneous-skeletal syndrome in which low bone mineral density (BMD) and osteoporosis are common. Low BMD is, however, not the sole component of fracture risk. In th
Autor:
Sirkku Peltonen, Maria H. Alanne, Eetu Heervä, Teuvo Hentunen, Juha Peltonen, Tommi Kuorilehto, Kalervo Väänänen
Publikováno v:
Bone. 47:583-590
Neurofibromatosis 1 syndrome (NF1) presents with skeletal involvement suggesting that altered bone dynamics is associated with NF1. Histological analysis of three cases of NF1-related pseudarthrosis revealed numerous osteoclasts in contact with adjac
Autor:
Juha Peltonen, Ludwine Messiaen, Marja Nissinen, Juha Risteli, Hannu-Ville Leskelä, Pentti Kinnunen, Tommi Kuorilehto, Petri Lehenkari, Jussi Koivunen, Sirkku Peltonen
Publikováno v:
Bone. 44:243-250
Three patients with neurofibromatosis 1 (NF1) were operated for congenital pseudarthrosis (PA) of the tibia. Three non-NF1 patients served as reference. Both NF1 mRNA and protein were detected in the PAs and in rows of osteoblasts and numerous osteoc
Autor:
Petri Lehenkari, Juha Peltonen, Tommi Kuorilehto, Pentti Kinnunen, Maria Alanne, Hannu-Ville Leskelä, Marja Nissinen
Publikováno v:
Pathology - Research and Practice. 202:687-690
Neurofibromatosis type 1 (NF1) is a common dominantly inherited disease. More than half of NF1 patients suffer from skeletal manifestations, of which congenital pseudarthrosis of tibia (CPT) is one of the most incapacitating lesions. Two NF1 patients
Autor:
Erika Ekholm, K Hietaniemi, Pekka Paavolainen, Risto Penttinen, Ari Hiltunen, Tommi Kuorilehto, Juha Peltonen, Marja Nissinen
Publikováno v:
Journal of Histochemistry & Cytochemistry. 54:363-370
Neurofibromatosis type 1 (NF1) is an inherited disease with an incidence of about 1:3000 worldwide. Approximately half of all patients with NF1 present osseous manifestations, which can vary from mild to severely debilitating changes such as congenit
Publikováno v:
Osteoporosis International. 16:928-936
Neurofibromatosis type 1 (NF1) is a dominantly inherited disease. Skeletal ailments such as short stature, kyphoscoliosis, tibial bowing and pseudarthrosis are common osseous manifestations of NF1. Previously, a correlation with scoliosis and decreas